Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]
Athos Therapeutics Announces Research Collaboration to Advance Precision Medicine in Inflammatory Bowel Disease
Athos Therapeutics, Inc. (“Athos”), a late-stage preclinical biotech company using artificial intelligence to develop small […]
Overjet Partners with Affinity Dental Management to Improve Lives through AI
Overjet announced today it has partnered with Affinity Dental Management to provide its practices with […]
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
Nosopharm Welcomes New Members To Supervisory Board
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial resistance, […]
Hansa Biopharma Announces First Patient Treated in the Post-authorization Efficacy Study (PAES) of Idefirix® (Imlifidase) in Highly Sensitized Kidney Transplant Patients
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, […]
Tampa General Hospital Offers New Treatment Option for Recurrent Brain Cancer to Improve Quality of Life
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients […]
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines
A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]
HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia
A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more